首页> 外文期刊>Cell death and differentiation >Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
【24h】

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation

机译:肝脏分泌的新型p53靶基因参与非细胞自主调节

获取原文
获取原文并翻译 | 示例
           

摘要

The tumor-suppressor p53 is a transcription factor that prevents cancer development and is involved in regulation of various physiological processes. This is mediated both by induction of cell cycle arrest and apoptosis and by controlling the expression of a plethora of target genes, including secreted proteins. It has been demonstrated that p53 may exert its effect in non-cell-autonomous manner by modulating the expression of genes that encode for secreted factors. In this study, we utilized our microarray data to identify and characterize novel p53 target genes expressed in human liver cells and associated with steroid hormones processing and transfer. We identified the steroid hormones binding factors, sex hormone-binding globulin (SHBG), corticosteroid-binding globulin (CBG) and cytochrome P450 family 21 subfamily A polypeptide 2, as novel p53 target genes. Their expression and secretion was increased following p53 activation in various hepatic cells. We observed that p53 wild-type mice exhibited higher levels of CBG compared with their p53 null counterparts. We demonstrated that the induction of the steroid hormones binding factors can be mediated by binding to specific p53 responsive elements within their promoters. In addition, utilizing conditioned medium experiments we have shown that p53-dependent induction of SHBG secretion from liver cells enhances apoptosis of breast cancer cells. Moreover, depletion of SHBG abolished the induction of breast cancer cells death. The newly identified p53 target genes suggest a novel non-cell-autonomous tumor-suppressive regulation mediated by p53 that is central for maintaining organism homeostasis.
机译:肿瘤抑制因子p53是防止癌症发展的转录因子,参与各种生理过程的调控。这是通过诱导细胞周期停滞和凋亡以及通过控制过多的靶基因(包括分泌的蛋白质)的表达来介导的。已经证明p53可以通过调节编码分泌因子的基因的表达来以非细胞自主方式发挥其作用。在这项研究中,我们利用我们的微阵列数据来鉴定和表征在人类肝细胞中表达并与类固醇激素加工和转移有关的新型p53靶基因。我们确定类固醇激素结合因子,性激素结合球蛋白(SHBG),皮质类固醇结合球蛋白(CBG)和细胞色素P450家族21亚家族A多肽2,作为新的p53靶基因。在各种肝细胞中p53激活后,它们的表达和分泌增加。我们观察到,p53野生型小鼠与其p53无效配对小鼠相比,显示出更高的CBG水平。我们证明,类固醇激素结合因子的诱导可通过结合至其启动子内的特定p53反应元件来介导。另外,利用条件培养基实验,我们已经表明,肝细胞SHBG分泌的p53依赖性诱导增强了乳腺癌细胞的凋亡。此外,SHBG的消耗消除了乳腺癌细胞死亡的诱导。新近鉴定的p53靶基因表明,由p53介导的新型非细胞自主性肿瘤抑制调节对于维持生物体内稳态至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号